Global Microbiome Therapeutics Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast 2016 - 2023

June 2017 | 107 pages | ID: GA94C99B439EN
Value Market Research

Abstracts

The report on global microbiome therapeutics market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2016-2023. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).

Drivers

• Increasing consumer awareness
• Robust product pipeline
• Restraints
• Cost factor

Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period:

Base Year: 2016
Estimated Year: 2017
Forecast Till: 2023

The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.

The report classifies the market into different segments based on type and application. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.

The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Enterome Bioscience, MaaT Pharma, MicroBiome Therapeutics LLC, OpenBiome, Rebiotix, Inc., Ritter Pharmaceuticals Inc., Second Genome and Seres Therapeutics Inc. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.

SEGMENTATIONS IN THE REPORT:

By Type:

• FMT
• Microbiome Drugs

By Applications:

• C. Difficile
• Crohn’s Disease
• Inflammatory Bowel Disease
• Diabetes
• Others

By Geography:

• North America (NA) – US, Canada & Rest of North America
• Europe (EU) – UK, Germany, France & Rest of Europe
• Asia Pacific (APAC) – China, Japan, India & Rest of APAC
• Latin America (LA) – Brazil & Rest of Latin America
• Middle East & Africa (MEA) – Middle East and Africa

Contents

1. INTRODUCTION

Report Description
Research Scope
Research Methodology

2. EXECUTIVE SUMMARY

Market Highlight
Global Microbiome Therapeutics Market: Snapshot

3. MARKET ANALYSIS

Introduction
Value Chain Analysis
Drivers
Restraints
Opportunities
Porter’s Five Forces Analysis

4. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY TYPE

Market In FMT
Market In Microbiome Drugs

5. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY APPLICATION

Market In C. Difficile
Market In Crohn’s Disease
Market In Inflammatory Bowel Disease
Market In Diabetes
Market In Others

6. MICROBIOME THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

North America (NA)
North America Market Estimates
North America Market Estimates By Country
United States (U.S.)
Canada
Rest Of North America
Europe (EU)
Europe Market Estimates
Europe Market Estimates By Country
United Kingdom (UK)
Germany
France
Rest Of Europe
Asia Pacific (APAC)
Asia Pacific Market Estimates
Asia Pacific Market Estimates By Country
China
Japan
India
Rest Of Asia Pacific
Latin America (LA)
Latin America Market Estimates
Latin America Market Estimates By Country
Brazil
Rest Of Latin America
Middle East And Africa (MEA)
Middle East And Africa Market Estimates
Middle East And Africa Market Estimates By Country
Middle East
Africa

7. COMPETITIVE LANDSCAPE OF THE MICROBIOME THERAPEUTICS COMPANIES

Market Competition
Partnerships/Collaborations/Agreements
Mergers And Acquisitions
New Product Launches
Other Developments

8. COMPANY PROFILES OF THE MICROBIOME THERAPEUTICS INDUSTRY (COMPANY OVERVIEW, FINANCIAL, MAJOR PRODUCTS & RECENT DEVELOPMENT)

Enterome Bioscience
MaaT Pharma
MicroBiome Therapeutics LLC
OpenBiome
Rebiotix, Inc.
Ritter Pharmaceuticals Inc.
Second Genome
Seres Therapeutics Inc.
Tentative TOC